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The head-up tilt test (HUTT) is a useful diagnostic tool for
evaluating suspected neurocardiogenic syncope. Pharmaco-
logic provocation with isoproterenol, adenosine, or nitro-
glycerin (NTG) is frequently used to facilitate the induction
of syncope during HUTT.1,2 Studies have reported the
occurrence of ventricular arrhythmias during HUTT, espe-
cially with high-dose isoprenaline infusion in patients with
structural heart disease.3,4Case report
A 55-year-old diabetic and hypertensive man presented with
3 episodes of syncope, all in upright posture, in the previous
1 and half years. He denied a history of angina, palpitation,
or dyspnea at any time, including prior to the episodes. The
patient was hospitalized after each episode and his vital
signs, electrocardiogram, and blood sugars were found to be
normal. He had no postural fall in blood pressure, carotids
were normal, and no evidence of carotid hypersensitivity was
noted. Echocardiogram was normal and Holter monitoring
did not reveal any signiﬁcant pause or arrhythmia. With the
possibility of neurocardiogenic syncope, HUTT was per-
formed using the Italian protocol.2 Brieﬂy, the procedure was
performed in the morning, after overnight fasting in a quiet,
slightly darkened room that had resuscitative equipment, and
was monitored by a cardiology resident and staff nurse. The
tilt test was performed by means of an electronically
controlled tilt table with a footboard for weight bearing.
Restraining belts were placed at chest and thigh levels. Blood
pressure, heart rate, and rhythm were continuously moni-
tored using limb lead 2, and were recorded every 25
minutes, or more often if symptoms developed. Head-up tilt
was performed after an initial observation with the patient inKEYWORDS Ventricular ﬁbrillation; Head-up tilt test; Nitroglycerin
ABBREVIATIONS HUTT ¼ head-up tilt test; ICD ¼ implantable
cardioverter-defibrillator; NTG ¼ nitroglycerin; VF ¼ ventricular
fibrillation (Heart Rhythm Case Reports 2015;1:363–365)
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).consecutive phases; during the ﬁrst phase, the patient was
tilted at 60 degrees for up to 45 minutes without medication.
Since baseline tilt did not induce syncope, the second phase
of the test was repeated with the patient being tilted to 60
degrees after 300 mcg of sublingual NTG. After 5 minutes of
upright tilt, the patient developed syncope, associated with
abrupt sinus pause that continued for 9 seconds (Figure 1A
and B), and as the patient was being lowered to supine
position this was followed by a brief episode of ventricular
ﬁbrillation (VF) (Figure 1C). While the deﬁbrillator was
being readied to deliver a DC shock, external cardiac
massage was being instituted and the VF terminated without
the necessity of a DC shock (Figure 1D), ﬁrst for a brief
period of asystole followed by resumption of sinus rhythm.
Subsequently, a treadmill test was performed on Bruce
protocol to evaluate for coronary artery disease, which was
strongly positive for inducible ischemia at 4 minutes of
exercise, with no angina during the test. Coronary angiogram
was performed and revealed triple vessel coronary artery
disease (Figure 2AD), for which the patient underwent
successful coronary artery bypass surgery. At 2 months
postsurgery, the patient underwent a repeat tilt table test, but
this time with a hands-free deﬁbrillator with external pacing
capability applied to the chest wall. The test was positive,
with an asystolic response of 6 seconds with no episode of
VF. It was decided to manage the patient with conservative
therapy with lifestyle modiﬁcation and consider pacing if
there were frequent recurrences of syncope. At 3 months
postsurgery the patient has been free of syncopal episodes.
Since the patient had a reversible cause of VF and normal
ventricular function, an implantable cardioverter-deﬁbrillator
(ICD) was not considered.Discussion
Head-up tilt test is a commonly used diagnostic tool for
evaluating suspected neurocardiogenic syncope. During
HUTT, if passive tilt does not induce syncope, isoprenaline,
adenosine, and NTG are the pharmacologic agents used to
facilitate the induction of syncope.1,2,5 A shortened oral NTG
test and low-dose isoproterenol test are the most accurate
head-up tilt protocols for this purpose, and their use has beenpen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2015.06.012
KEY TEACHING POINTS
 Reversible ischemia should be ruled out prior to
head-up tilt test (HUTT) in patients with risk
factors and/or structural heart disease.
 In patients with structural heart disease, if HUTT is
to be performed after ruling out reversible
ischemia, use of a hands-free deﬁbrillator is
recommended while performing the test.
 It is preferable to avoid provocation with
pharmacologic agents in patients with known
ischemic heart disease, especially high-dose
isoprenaline.
 HUTT should be avoided in patients with reversible
ischemia, and if it needs to be done at all, it should
be performed with due care after complete
revascularization.
 Sublingual nitroglycerin should be avoided in
patients with ischemic heart disease and history of
syncope.
Heart Rhythm Case Reports, Vol 1, No 5, September 2015364recently recommended by the Task Force on Syncope of the
European Society of Cardiology.6 Incidence of VF with
HUTT is extremely rare (0.04%) and has occurred with high-
dose (5 μg/min) isoprenaline infusion in patients with either
undiagnosed underlying signiﬁcant coronary artery disease,
known structural heat disease, or apical hypertrophic car-
diomyopathy.3,4,7 VF has not been reported with the use of
NTG. In the present case the mechanism of VF can only beFigure 1 AD: Continuous tracing of lead II during head-up tilt test. Panel A s
(B); this is followed by the onset of ventricular ﬁbrillation (VF) (C) and external
artifacts related to cardiac massage and (D) sinus rhythm resumes. CPR ¼ cardiopostulated. NTG acts as a provocative agent during tilt
testing because of its potent vasodilator effects on the
capacity vessels, causing venous pooling, enhanced by
upright posture. It is likely that the prolonged asystole
resulted in regional myocardial ischemia in the presence of
signiﬁcant coronary artery disease. Whenever there is abrupt
and prolonged arrest of ﬂow to the myocardium, it deprives
ventricular myocytes of oxygen, causing rapid inhibition
of oxidative phosphorylation and a switch to anaerobic
glycolysis for production of high-energy phosphates. This
transition has several important consequences and results in
steep gradients of metabolic, ionic, and neurogenic changes
specially to be present at the ischemic boundaries. Catechol-
amines released locally in ischemic myocardium contribute to
the changes in electrophysiologic parameters during ischemia
and play a role in the susceptibility of hearts to VF during
regional ischemia.8 It is quite likely that NTG itself is not
responsible for ventricular tachyarrhythmia. The termination of
VF in the present case was possibly spontaneous. Spontaneous
termination of VF, though rare, has been reported before.9
It is interesting to note that there has been no incidence of
ventricular arrhythmias reported in a large study in the
absence of provocative agents.7 It has been reported that as
many as 35% of patients with syncope and structural heart
disease have neurally mediated syncope, and it may be
necessary to perform a tilt test as part of the evaluation of
patients with structural heart disease.4 Most cases of VF during
HUTT have occurred in patients with signiﬁcant underlying
coronary artery disease and reversible ischemia.3,4 It is advisible
to rule out reversible ischemia prior to HUTT in patients with
risk factors and/or structural heart disease. In patients with
structural heart disease, if HUTT is to be performed after rulinghows gradual bradycardia followed by asystole that continues for 9 seconds
cardiac massage is initiated.Thin arrows mark QRS complexes within the
pulmonary resuscitation.
Figure 2 Coronary angiogram inA: left anterior oblique cranial, B: right anterior oblique caudal, andC: cranial views showing signiﬁcant lesions in proximal
left anterior descending artery. D: The right coronary artery was totally occluded at the proximal segment.
365Shenthar et al Ventricular Fibrillation During Head-Up Tilt Testout reversible ischemia, it is prudent to avoid high-dose
isoprenaline and to use a hands-free deﬁbrillator while perform-
ing the test.
The incidence of ventricular asystole during spontaneous
neurocardiogenic syncope does not imply a poor progn-
osis in terms of syncopal recurrences or sudden death.10
Ventricular asystole observed during HUTT, even when
prolonged, is usually not indicative of a more advanced
disease and/or serious future clinical events, such as frequent
syncopal recurrences, important syncope-related injuries,
and sudden death. Implantation of a pacemaker or drug
treatment in patients with asystolic response is not associated
with a lower syncopal rate during the follow-up.11 Hence it is
suggested that an aggressive treatment with pacemaker
should not be the standard therapy for all tilt-induced
asystole, but should be reserved only for selected cases, on
a single-patient basis.10 In the present case we did not offer
pacemaker therapy but will continue to monitor the patient.
The patient was also not offered an ICD, as the guidelines do
not support the use of ICDs in reversible causes of VF and
normal ventricular function.12 To the best of our knowledge,
occurrence of VF during HUTT with NTG challenge has not
been reported previously in the literature. It is also recom-
mended that nitrates in the form of sublingual tablets or spray
be avoided in patients with ischemic heart disease and
history of syncope. HUTT should be avoided in patie-
nts with reversible ischemia, and if it needs to be done at
all, it should be performed with due care after complete
revascularization.References
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